Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2018

01-02-2018 | UNM Clinical Case Conferences

Carbamazepine-Associated Hypersensitivity Colitis

Authors: Wa’el Tuqan, Sarah Lee, Joshua Hanson, Denis McCarthy

Published in: Digestive Diseases and Sciences | Issue 2/2018

Login to get access

Excerpt

A 26-year-old man with a history of bipolar disorder was transferred from an outside hospital with possible Stevens–Johnsons syndrome in the setting of worsening skin rash and subacute bloody diarrhea. Two months previously, he had been admitted to a psychiatric facility following a manic episode and was treated with carbamazepine 200 mg twice a day, lithium 900 mg at bedtime, gabapentin 100 mg three times a day, and mirtazapine 7.5 mg at bedtime. One month later, he developed raised flat lesions on his extremities that progressively spread to his entire body, including his face. Owing to these developments, his psychiatrist had started him prior to this admission on oral prednisone that did not improve his condition. Furthermore, he was taking over-the-counter ibuprofen 400 mg every 4–6 h and acetaminophen 500 mg daily for generalized pain of the rash and diffuse joint pain. He denied use of any herbal supplements or alcohol. Over the following 2 weeks, he had developed bloody diarrhea with associated abdominal cramping for which he was briefly evaluated at an outside hospital prior to rapid transfer to this medical center. …
Literature
2.
go back to reference Eland IA, Dofferhoff AS, Vink R, et al. Colitis may be part of the antiepileptic drug hypersensitivity syndrome. Epilepsia. 1999;40:1780–1783.CrossRefPubMed Eland IA, Dofferhoff AS, Vink R, et al. Colitis may be part of the antiepileptic drug hypersensitivity syndrome. Epilepsia. 1999;40:1780–1783.CrossRefPubMed
3.
go back to reference Upala S, Wijarnpreecha K, Jaruvongvanich V, et al. Antipsychotics-induced ischemic colitis. Am J Emerg Med. 2015;33:1716.CrossRefPubMed Upala S, Wijarnpreecha K, Jaruvongvanich V, et al. Antipsychotics-induced ischemic colitis. Am J Emerg Med. 2015;33:1716.CrossRefPubMed
4.
go back to reference Rzany B, Correia O, Kelly JP, et al. Risk of Stevens–Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study group of the international case control study on severe cutaneous adverse reactions. Lancet. 1999;353:2190–2194.CrossRefPubMed Rzany B, Correia O, Kelly JP, et al. Risk of Stevens–Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study group of the international case control study on severe cutaneous adverse reactions. Lancet. 1999;353:2190–2194.CrossRefPubMed
5.
go back to reference Choudhary S, McLeod M, Torchia D, Romanelli P. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. J Clin Aesthet Dermatol. 2013;6:31–37.PubMedPubMedCentral Choudhary S, McLeod M, Torchia D, Romanelli P. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. J Clin Aesthet Dermatol. 2013;6:31–37.PubMedPubMedCentral
6.
go back to reference Peyriere H, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2006;155:422–428.CrossRefPubMed Peyriere H, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2006;155:422–428.CrossRefPubMed
7.
go back to reference Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156:1083–1084.CrossRefPubMed Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156:1083–1084.CrossRefPubMed
8.
go back to reference Atkinson RJ, Dennis G, Cross SS, et al. Eosinophilic colitis complicating anti-epileptic hypersensitivity syndrome: an indication for colonoscopy? Gastrointest Endosc. 2004;60:1034–1036.CrossRefPubMed Atkinson RJ, Dennis G, Cross SS, et al. Eosinophilic colitis complicating anti-epileptic hypersensitivity syndrome: an indication for colonoscopy? Gastrointest Endosc. 2004;60:1034–1036.CrossRefPubMed
9.
go back to reference Anttila VJ, Valtonen M. Carbamazepine-induced diarrhea and eosinophilic inflammation of the colon. Duodecim. 1990;106:372–374.PubMed Anttila VJ, Valtonen M. Carbamazepine-induced diarrhea and eosinophilic inflammation of the colon. Duodecim. 1990;106:372–374.PubMed
10.
11.
go back to reference Sarantidis D, Waters B. A review and controlled study of cutaneous conditions associated with lithium carbonate. Br J Psychiatry. 1983;143:42–50.CrossRefPubMed Sarantidis D, Waters B. A review and controlled study of cutaneous conditions associated with lithium carbonate. Br J Psychiatry. 1983;143:42–50.CrossRefPubMed
12.
go back to reference Bains A. Lithium-induced drug reaction with eosinophilia and systemic symptom syndrome. Indian J Dermatol. 2017;62:532–533.PubMedPubMedCentral Bains A. Lithium-induced drug reaction with eosinophilia and systemic symptom syndrome. Indian J Dermatol. 2017;62:532–533.PubMedPubMedCentral
13.
go back to reference Shreedhar K, Madhukara J, Jessy J, et al. Drug hypersensitivity syndrome with lithium. Indian J Dermatol Venereol Leprol. 2010;76:426–427.CrossRefPubMed Shreedhar K, Madhukara J, Jessy J, et al. Drug hypersensitivity syndrome with lithium. Indian J Dermatol Venereol Leprol. 2010;76:426–427.CrossRefPubMed
15.
go back to reference Tas S, Simonart T. Drug Rash with eosinophilia and systemic symptoms (Dress syndrome). Acta Clin Belg. 1999;54:197–200.PubMed Tas S, Simonart T. Drug Rash with eosinophilia and systemic symptoms (Dress syndrome). Acta Clin Belg. 1999;54:197–200.PubMed
16.
go back to reference Osman A, Ibrahim W, Khanjar I, et al. Sudden worsening of DRESS syndrome on tapering steroid dose with dramatic improvement on N-acetylcysteine and steroid dose escalation. Ibnosina J Med Biomed Sci. 2013;6:101–105. Osman A, Ibrahim W, Khanjar I, et al. Sudden worsening of DRESS syndrome on tapering steroid dose with dramatic improvement on N-acetylcysteine and steroid dose escalation. Ibnosina J Med Biomed Sci. 2013;6:101–105.
17.
go back to reference Chiou CC, Yang LC, Hung SI, et al. Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol. 2008;22:1044–1049.CrossRefPubMed Chiou CC, Yang LC, Hung SI, et al. Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol. 2008;22:1044–1049.CrossRefPubMed
18.
go back to reference Gentile I, Talamo M, Borgia G. Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review. BMC Infect Dis. 2010;10:49.CrossRefPubMedPubMedCentral Gentile I, Talamo M, Borgia G. Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review. BMC Infect Dis. 2010;10:49.CrossRefPubMedPubMedCentral
19.
go back to reference Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part II. Management and therapeutics. J Am Acad Dermatol. 2013;68:709.e1–709.e9.CrossRef Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part II. Management and therapeutics. J Am Acad Dermatol. 2013;68:709.e1–709.e9.CrossRef
20.
go back to reference Zuliani E, Zwahlen H, Gilliet F, Marone C. Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. Clin Nephrol. 2005;64:155–158.CrossRefPubMed Zuliani E, Zwahlen H, Gilliet F, Marone C. Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. Clin Nephrol. 2005;64:155–158.CrossRefPubMed
21.
go back to reference Dar W, Latief M, Sofi N, et al. DRESS syndrome: a review and update. Skin Dis Skin Care. 2016;1:1–8. Dar W, Latief M, Sofi N, et al. DRESS syndrome: a review and update. Skin Dis Skin Care. 2016;1:1–8.
Metadata
Title
Carbamazepine-Associated Hypersensitivity Colitis
Authors
Wa’el Tuqan
Sarah Lee
Joshua Hanson
Denis McCarthy
Publication date
01-02-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4881-7

Other articles of this Issue 2/2018

Digestive Diseases and Sciences 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine